Laminopathies: The molecular background of the disease and the prospects for its treatment

• Autorzy: Zaremba-Czogalla M. , Dubinska-Magiera M. , Rzepecki R.
• Języki publikacji: EN

Abstrakty

EN

Laminopathies are rare human degenerative disorders with a wide spectrum of clinical phenotypes, associated with defects in the main protein components of the nuclear envelope, mostly in the lamins. They include systemic disorders and tissue-restricted diseases. Scientists have been trying to explain the pathogenesis of laminopathies and find an efficient method for treatment for many years. In this review, we discuss the current state of knowledge about laminopathies, the molecular mechanisms behind the development of particular phenotypes, and the prospects for stem cell and/or gene therapy treatments.

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2011
• Tom: 16
• Numer: 1
• Opis fizyczny: p.114-148,fig.ref.

Twórcy

autor

Zaremba-Czogalla M.

• Laboratory of Nuclear Proteins, Faculty of Biotechnology, University of Wroclaw, ul.Przybyszewskiego 63/77, 51-148 Wroclaw, Poland

autor

Dubinska-Magiera M.

autor

Rzepecki R.

Bibliografia

• 1. Worman, H.J., Fong, L.G., Muchir, A. and Young, S.G. Laminopathies and the long strange trip from basic cell biology to therapy. J. Clin. Invest. 119 (2009) 1825-1836.
• 2. Worman, H.J., Fong, L.G., Muchir, A. and Young, S.G. The nuclear envelope from basic biology to therapy. Biochem. Soc. Trans. 38 (2010) 253-256.
• 3. Foster, C.R., Przyborski, S.A., Wilson, R.G. and Hutchison, C.J. Lamins as cancer biomarkers. Biochem. Soc. Trans. 38 (2010) 297-300.
• 4. Hetzer, M.W. The Nuclear Envelope. Cold Spring Harb. Perspect Biol. (2010) cshperspect.a000539.
• 5. Rzepecki, R., Smithe, C. and Hutchison, C.J. The role of mitotic vesicles in the nuclear assembly. Cell. Mol. Biol. Lett. 7 (2002) 299.
• 6. Herrmann, H., Bar, H., Kreplak, L., Strelkov, S.V. and Aebi, U. Intermediate filaments: from cell architecture to nanomechanics. Nat. Rev. Mol. Cell Biol. 8 (2007) 562-573.
• 7. Dechat, T., Pfleghaar, K., Sengupta, K., Shimi, T., Shumaker, D.K., Solimando, L. and Goldman, R.D. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev. 22 (2008) 832-853.
• 8. Liu, Q., Kim, D.I., Syme, J., LuValle, P., Burke, B. and Roux, K.J. Dynamics of lamin-A processing following precursor accumulation. PLoS One 5 (2010) e10874.
• 9. Prokocimer, M., Davidovich, M., Nissim-Rafinia, M., Wiesel-Motiuk, N., Bar, D., Barkan, R., Meshorer, E. and Gruenbaum, Y. Nuclear lamins: key regulators of nuclear structure and activities. J. Cell. Mol. Med. 13 (2009) 1059-1085.
• 10. Zaremba-Czogalla, M., Dubińska-Magiera, M. and Rzepecki, R. [Nowe funkcje lamin - starzy znajomi w nowym świetle]. Postępy Biologii Komórki 37 (2010) 1-18.
• 11. Bonne, G., Di Barletta, M.R., Varnous, S., Becane, H.M., Hammouda, H.E., Merlini, L., Muntoni, F., Greenberg, C.R., Gary, F., Urtizberea, J.A., Duboc, D., Fardeau, M., Toniolo, D. and Schwartz, K. Mutations in the gene encoding laminA/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nature Genet. 21 (1999) 285-288.
• 12. Di Barletta, M., Ricci, E., Galluzzi, G., Tonali, P., Mora, M., Morandi, L., Romorini, A., Voit, T., Orstavik, K.H. and Merlini, L. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive EmeryDreifuss muscular dystrophy. Am. J. Hum. Genet. 66 (2000) 1407-1412.
• 13. Muchir, A., Bonne, G., van der Kooi, A.J., van Meegen, M., Baas, F., Bolhuis, P.A., de Visser, M. and Schwartz, K. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 9 (2000) 1453-1459.
• 14. Fatkin, D., MacRae, C., Sasaki, T., Wolff, M.R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H.J., Spudich, S., De Girolami, U., Seidman, J.G., Seidman, C., Muntoni, F., Muehle, G., Johson, W. and McDonough, B. Missense mutations in the rod domain in the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. New Eng. J. Med. 341 (1999) 1715-1724.
• 15. Bione, S., Maestrini, E., Rivella, S., Mancini, M., Regis, S., Romeo, G. and Toniolo, D. Identification of a novel X-linked gene responsible for EmeryDreifuss muscular dystrophy. Nat. Genet. 8 (1994) 323-327.
• 16. Renou, L., Stora, S., Yaou, R.B., Volk, M., Sinkovec, M., Demay, L., Richard, P., Peterlin, B. and Bonne, G. Heart-hand syndrome of Slovenian type: a new kind of laminopathy. J. Med. Genet. 45 (2008) 666-671.
• 17. Cao, H. and Hegele, R.A. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9 (2000) 109-112.
• 18. Drac, H., Madej-Pilarczyk, A., Gospodarczyk-Szot, K., Gaweł, M., Kwieciński, H. and Hausmanowa-Petrusewicz, I. Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G>A (Arg482Gln) in a Polish family. Neurol. Neurochir. Pol. 44 (2010) 291-296.
• 19. Hegele, R.A., Cao, H., Liu, D.M., Costain, G.A., Charlton-Menys, V., Rodger, N.W. and Durrington, P.N. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am. J. Hum. Genet. 79 (2006) 383-389.
• 20. Young, J., Morbois-Trabut, L., Couzinet, B., Lascols, O., Dion, E., Bereziat, V., Feve, B., Richard, I., Capeau, J., Chanson, P. and Vigouroux, C. Type A insulin resistance syndrome revealing a novel lamin A mutation. Diabetes 54 (2005) 1873-1878.
• 21. De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C.L., Munnich, A., Le Merrer, M. and Levy, N. Lamin a truncation in Hutchinson-Gilford progeria. Science 300 (2003) 2055.
• 22. Chen, L., Lee, L., Kudlow, B., Dos Santos, H., Sletvold, O., Shafeghati, Y., Botha, E., Garg, A., Hanson, N., Martin, G.M., Mian, I.S., Kennedy, B.K. and Oshima, J. LMNA mutations in atypical Werner's syndrome. Lancet 362 (2003) 440-445.
• 23. Navarro, C.L., Cadinanos, J., De Sandre-Giovannoli, A., Bernard, R., Courrier, S., Boccaccio, I., Boyer, A., Kleijer, W.J., Wagner, A., Giuliano, F., Beemer, F.A., Freije, J.M., Cau, P., Hennekam, R.C., Lopez-Otin, C., Badens, C. and Levy, N. Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum. Mol. Genet. 14 (2005) 1503-1513.
• 24. Agarwal, A.K., Fryns, J.P., Auchus, R.J. and Garg, A. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum. Mol .Genet. 12 (2003) 1995-2001.
• 25. Novelli, G., Muchir, A., Sangiuolo, F., Helbling-Leclerc, A., D'Apice, M.R., Massart, C., Capon, F., Sbraccia, P., Federici, M., Lauro, R., Tudisco, C., Pallotta, R., Scarano, G., Dallapiccola, B., Merlini, L. and Bonne, G. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 71 (2002) 426-431.
• 26. Hoffmann, K., Dreger, C.K., Olins, A.L., Olins, D.E., Shultz, L.D., Lucke, B., Karl, H., Kaps, R., Muller, D., Vaya, A., Aznar, J., Ware, R.E., Cruz, N.S., Lindner, T.H., Herrmann, H., Reis, A. and Sperling, K. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huet anomaly). Nat. Genet. 31 (2002) 410-414.
• 27. Garg, A., Subramanyam, L., Agarwal, A.K., Simha, V., Levine, B., D'Apice, M.R., Novelli, G. and Crow, Y. Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J. Clin. Endocrinol. Metab. 94 (2009) 4971-4983.
• 28. De Sandre-Giovannoli, A., Chaouch, M., Kozlov, S., Vallat, J.M., Tazir, M., Kassouri, N., Szepetowski, P., Hammadouche, T., Vandenberghe, A., Stewart, C.L., Grid, D. and Levy, N. Homozygous defects in LMNA, encoding lamin A/C nuclear envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 70 (2002) 726-736.
• 29. Padiath, Q.S., Saigoh, K., Schiffmann, R., Asahara, H., Yamada, T., Koeppen, A., Hogan, K., Ptacek, L.J. and Fu, Y.H. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat. Genet. 38 (2006) 1114-1123.
• 30. Vantyghem, M.C., Pigny, P., Maurage, C.A., Rouaix-Emery, N., Stojkovic, T., Cuisset, J.M., Millaire, A., Lascols, O., Vermersch, P., Wemeau, J.L., Capeau, J. and Vigouroux, C. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. J. Clin. Endocrinol. Metab. (2004) 5337-5346.
• 31. Vantyghem, M.C., Faivre-Defrance, F., Marcelli-Tourvieille, S., Fermon, C., Evrard, A., Bourdelle-Hego, M.F., Vigouroux, C., Defebvre, L., Delemer, B. and Wemeau, J.L. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism. Clin. Endocrinol (Oxf). 67 (2007) 247-249.
• 32. Benedetti, S., Bertini, E., Iannaccone, S., Angelini, C., Trisciani, M., Toniolo, D., Sferrazza, B., Carrera, P., Comi, G., Ferrari, M., Quattrini, A. and Previtali, S.C. Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1019-1021.
• 33. Goizet, C., Yaou, R., Demay, L., Richard, P., Bouillot, S., Rouanet, M., Hermosilla, E., Le Masson, G., Lagueny, A., Bonne, G. and Ferrer, X. A new mutation of the lamin A/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia. J. Med. Genet. 41 (2004) e29.
• 34. Hegele, R.A. and Oshima, J. Phenomics and lamins: from disease to therapy. Exp. Cell Res. 313 (2007) 2134-2143.
• 35. Harborth, J., Elbashir, S.M., Bechert, K., Tuschl, T. and Weber, K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114 (2001) 4557-4565.
• 36. Vergnes, L., Peterfy, M., Bergo, M.O., Young, S.G. and Reue, K. Lamin B1 is required for mouse development and nuclear integrity. Proc. Natl. Acad. Sci. USA 101 (2004) 10428-10433.
• 37. Coffinier, C., Chang, S.Y., Nobumori, C., Tu, Y., Farber, E.A., Toth, J.I., Fong, L.G. and Young, S.G. Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency. Proc. Natl. Acad. Sci. USA 107 (2010) 5076-5081.
• 38. Waterham, H.R., Koster, J., Mooyer, P., van Noort, G., Kelley, R.I., Wilcox, W.R., Wanders, R.J.A., Hennekam, R.C.M. and Oosterwijk, J.C. Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3betahydroxysterol delta14-reductase deficiency due to mutations in the lamin B receptor gene. Am. J. Hum. Genet. 72 (2003) 1013-1017.
• 39. Yuste-Chaves, M., Cañueto, J., Santos-Briz, A., Ciria, S., GonzálezSarmiento, R. and Unamuno, P. Buschke-Ollendorff Syndrome with Striking Phenotypic Variation Resulting from a Novel c.2203C>T Nonsense Mutation in LEMD3. Pediatr. Dermatol. (2010) DOI: 10.1111/j.1525- 1470.2010
• 40. Taylor, M.R., Slavov, D., Gajewski, A., Vlcek, S., Ku, L., Fain, P.R., Carniel, E., Di Lenarda, A., Sinagra, G., Boucek, M.M., Cavanaugh, J., Graw, S.L., Ruegg, P., Feiger, J., Zhu, X., Ferguson, D.A., Bristow, M.R., Gotzmann, J., Foisner, R. and Mestroni, L. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum. Mutat. 26 (2005) 566-574.
• 41. Landires, I., Pascale, J.M. and Motta, J. The position of the mutation within the LMNA gene determines the type and extent of tissue involvement in laminopathies. Clin. Genet. 71 (2007) 592-593.
• 42. Scharner, J., Gnocchi, V.F., Ellis, J.A. and Zammit, P.S. Genotypephenotype correlations in laminopathies: how does fate translate? BMC Dev. Biol. 38 (2010) 257-262.
• 43. Simon, D.N., Zastrow, M.S. and Wilson, K.L. Direct actin binding to A- and B-type lamin tails and actin filament bundling by the lamin A tail. Nucleus 1 (2010) 264-272.
• 44. Magracheva, E., Kozlov, S., Stewart, C.L., Wlodawer, A. and Zdanov, A. Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD). Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 65 (2009) 665-670.
• 45. Sewry, C. Muscular dystrophies: an update on pathology and diagnosis. Acta Neuropathol. 120 (2010) 343-358.
• 46. Rzepecki, R. The nuclear lamins and nuclear envelope. Cel. Mol. Biol. Lett. 7 (2002) 1019-1035.
• 47. Chmielewska, M., Dubińska-Magiera, M., Sopel, M., Rzepecka, D., Hutchison, C.J., Goldberg, M.W. and Rzepecki, R. Embryonic and adult isoforms of XLAP2 form microdomains associated with chromatin and the nuclear envelope. Cell Tissue Res. (2011), in press.
• 48. Margalit, A., Brachner, A., Gotzmann, J., Foisner, R. and Gruenbaum, Y. Barrier-to-autointegration factor--a BAFfling little protein. Trends Cell Biol. 17 (2007) 202-208.
• 49. Emery, A.E. and Dreifuss, F.E. Unusual type of benign X-linked muscular dystrophy. J. Neurol. Neurosurg. Psychiatry 29 (1966) 338-342.
• 50. Vaughan, O.A., Alvarez-Reyes, M., Bridger, J.M., Broers, J.L.V., Ramaekers, F.C.S., Wehnert, M., Morris, G.E., Whitfield, W.G.F. and Hutchison, C.J. Both emerin and lamin C depend on lamin A for localization at the nuclear envelope. J. Cell Sci. 114 (2001) 2577-2590.
• 51. Wheeler, M.A. and Ellis, J.A. Molecular signatures of Emery-Dreifuss muscular dystrophy. Biochem. Soc. Trans. 36 (2008) 1354-1358.
• 52. Gueneau, L., Bertrand, A.T., Jais, J.P., Salih, M.A., Stojkovic, T., Wehnert, M., Hoeltzenbein, M., Spuler, S., Saitoh, S., Verschueren, A., Tranchant, C., Beuvin, M., Lacene, E., Romero, N.B., Heath, S., Zelenika, D., Voit, T., Eymard, B., Ben Yaou, R. and Bonne, G. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 85 (2009) 338-353.
• 53. Zhang, Q., Bethmann, C., Worth, N.F., Davies, J.D., Wasner, C., Feuer, A., Ragnauth, C.D., Yi, Q., Mellad, J.A., Warren, D.T., Wheeler, M.A., Ellis, J.A., Skepper, J.N., Vorgerd, M., Schlotter-Weigel, B., Weissberg, P.L., Roberts, R.G., Wehnert, M. and Shanahan, C.M. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum. Mol. Genet. 16 (2007) 2816-2833.
• 54. Taylor, M.R.G., Fain, P.R., Sinagra, G., Robinson, M.L., Robertson, A.D., Carniel, E., Di Lenarda, A., Bohlmeyer, T.J., Ferguson, D.A., Brodsky, G.L., Boucek, M.M., Lascor, J., Moss, A.C., Li, W.-L.P., Stetler, G.L., Muntoni, F., Bristow, M.R., Mestroni, L. and Group, F.D.C.R.R. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J. Am. Coll. Cardiol. 41 (2003) 771-780.
• 55. Arbustini, E., Pilotto, A., Repetto, A., Grasso, M., Negri, A., Diegoli, M., Campana, C., Scelsi, L., Baldini, E., Gavazzi, A. and Tavazzi, L. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J. Am. Coll. Cardiol. 39 (2002) 981-990.
• 56. Muchir, A. and Worman, H.J. Emery-Dreifuss muscular dystrophy. Curr. Neurol. Neurosci. Rep. 7 (2007) 78-83.
• 57. Quijano-Roy, S., Mbieleu, B., Bönnemann, C.G., Jeannet, P.Y., Colomer, J., Clarke, N.F., Cuisset, J.M., Roper, H., De Meirleir, L., D'Amico, A., Ben Yaou, R., Nascimento, A., Barois, A., Demay, L., Bertini, E., Ferreiro, A., Sewry, C.A., Romero, N.B., Ryan, M., Muntoni, F., Guicheney, P., Richard, P., Bonne, G. and Estournet, B. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann. Neurol. 64 (2008) 177-186.
• 58. Dahl, K.N., Booth-Gauthier, E.A. and Ladoux, B. In the middle of it all: mutual mechanical regulation between the nucleus and the cytoskeleton. J. Biomech. 43 (2010) 2-8.
• 59. Attali, R., Warwar, N., Israel, A., Gurt, I., McNally, E., Puckelwartz, M., Glick, B., Nevo, Y., Ben-Neriah, Z. and Melki, J. Mutation of SYNE-1, encoding an essential component of the nuclear lamina, is responsible for autosomal recessive arthrogryposis. Hum. Mol. Genet. 18 (2009) 3462-3469.
• 60. Gros-Louis, F., Dupré, N., Dion, P., Fox, M.A., Laurent, S., Verreault, S., Sanes, J.R., Bouchard, J.P. and Rouleau, G.A. Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat. Genet. 39 (2007) 80-85.
• 61. Holaska, J.M. and Wilson, K.L. An emerin “proteome”: purification of distinct emerincontaining complexes from HeLa cells suggests molecular basis for diverse rolesincluding gene regulation, mRNA splicing, signaling, mechanosensing, and nu clear architecture. Biochemistry 46 (2007) 8897-8908.
• 62. Andrés, V. and González, J.M. Role of A-type lamins in signaling, transcription, and chromatin organization. J. Cell Biol. 187 (2009) 945-957.
• 63. Marmiroli, S., Bertacchini, J., Beretti, F., Cenni, V., Guida, M., De Pol, A., Maraldi, N.M. and Lattanzi, G. A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward. J. Cell. Physiol. 220 (2009) 553-561.
• 64. Kim, E.K. and Choi, E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 1802 (2010) 396-405.
• 65. González, J.M., Navarro-Puche, A., Casar, B., Crespo, P. and Andrés, V. Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J. Cell Biol. 183 (2008) 653-666.
• 66. Muchir, A., Pavlidis, P., Bonne, G., Hayashi, Y.K. and Worman, H.J. Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy. Hum. Mol. Genet. 16 (2007) 1884-1895.
• 67. Muchir, A., Pavlidis, P., Decostre, V., Herron, A.J., Arimura, T., Bonne, G. and Worman, H.J. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J. Clin. Invest. 117 (2007) 1282-1293.
• 68. Muchir, A., Wu, W. and Worman, H.J. Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells. Biochim. Biophys. Acta 1792 (2009) 75-81.
• 69. Emerson, L.J., Holt, M.R., Wheeler, M.A., Wehnert, M., Parsons, M. and Ellis, J.A. Defects in cell spreading and ERK1/2 activation in fibroblasts with lamin A/C mutations. Biochim. Biophys. Acta 1792 (2009) 810-821.
• 70. Muchir, A., Shan, J., Bonne, G., Lehnart, S.E. and Worman, H.J. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum. Mol. Genet. 18 (2009) 241-247.
• 71. Wu, W., Shan, J., Bonne, G., Worman, H.J. and Muchir, A. Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene. Biochim. Biophys. Acta 1802 (2010) 632-638.
• 72. MacDonald, B.T., Tamai, K. and He, X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17 (2009) 9-26.
• 73. Markiewicz, E., Tilgner, k., Barker, N., van de Wetering, M., Clevers, H., Dorobek, M., Hausmanowa-Petrusewicz, I., Ramaekers, F.C., Broers, J.L., Blankesteijn, W.M., Salpingidou, G., Wilson, R.G., Ellis, J.A. and Hutchison, C.J. The inner nuclear membrane protein emerin regulates betacatenin activity by restricting its accumulation in the nucleus. EMBO J. 25 (2006) 3275-3285.
• 74. Hoppler, S. and Kavanagh, C.L. Wnt signalling: variety at the core. J. Cell Sci. 120 (2007) 385-393.
• 75. Goichberg, P., Shtutman, M., Ben-Zeev, A. and Geiger, B. Recruitment of β-catenin to cadherin-mediated intercellular adhesions is involved in myogenic induction. J. Cell Sci. 114 (2001) 1309-1319.
• 76. Perez-Ruiz, A., Ono, Y., Gnocchi, V.F. and Zammit, P.S. β-catenin promotes self-renewal of skeletal-muscle satellite cells J. Cell Sci. 121 (2008) 1373-1382.
• 77. Hutchison, C.J. and Worman, H.J. A-type lamins: Guardians of the soma? Nat. Cell Biol. 6 (2004) 1062-1067.
• 78. Johnson, B.R. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc. Natl. Acad. Sci. USA 101 (2004) 9677-9682.
• 79. Markiewicz, E., Dechat, T., Foisner, R., Quinlan, R.A. and Hutchison, C.J. Lamin A/C binding protein LAP2 alpha is required for nuclear anchorage of retinoblastoma protein. Mol. Biol. Cell. 13 (2002) 4401-4413.
• 80. Frock, R.L., Kudlow, B.A., Evans, A.M., Jameson, S.A., Hauschka, S.D. and Kennedy, B.K. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev. 20 (2006) 486-500.
• 81. Naetar, N. and Foisner, R. Lamin complexes in the nuclear interior control progenitor cell proliferation and tissue homeostasis. Cell Cycle 8 (2009) 1488-1493.
• 82. Massagué, J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1 (2000) 169-178.
• 83. Van Berlo, J.H., Voncken, J.W., Kubben, N., Broers, J.L., Duisters, R., van Leeuwen, R.E., Crijns, H.J., Ramaekers, F.C., Hutchison, C.J. and Pinto, Y.M. A-type lamins are essential for TGF-{beta}1 induced PP2A to dephosphorylate transcription factors. Hum. Mol. Genet. 14 (2005) 2839-2849.
• 84. Puri, P.L., Iezzi, S., Stiegler, P., Chen, T.T., Schiltz, R.L., Muscat, G.E., Giordano, A., Kedes, L., Wang, J.Y. and Sartorelli, V. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol. Cell. 8 (2001) 885-897.
• 85. Park, Y.E., Hayashi, Y.K., Goto, K., Komaki, H., Hayashi, Y., Inuzuka, T., Noguchi, S., Nonaka, I. and Nishino, I. Nuclear changes in skeletal muscle extend to satellite cells in autosomal dominant Emery-Dreifuss muscular dystrophy/limb-girdle muscular dystrophy 1B. Neuromuscul. Disord. 19 (2008) 29-36.
• 86. Meshorer, E. and Gruenbaum, Y. Gone with the Wnt/Notch: stem cells in laminopathies, progeria, and aging. J. Cell Biol. 181 (2008) 9-13.
• 87. Jones, D.L. and Wagers, A.J. No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell. Biol. 9 (2008) 11-21.
• 88. Favreau, C., Higuet, D., Courvalin, J.C. and Buendia, B. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol. Cell. Biol. 24 (2004) 1481-1492.
• 89. Takai, H., Yamada, T., Tada, S. and Matsumaru, I. Successful surgical repair for Emery-Dreifuss muscular dystrophy valvular disease with longterm follow-up. Interac. Cardiovasc. Thorac. Surg. 10 (2010) 811-812.
• 90. Dechat, T., Shimi, T., Adam, S.A., Rusinol, A.E., Andres, D.A., Spielmann, H.P., Sinensky, M.S. and Goldman, R.D. Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc. Natl. Acad. Sci. USA 104 (2007) 4955-4960.
• 91. Rodriguez, S., Coppedè, F., Sagelius, H. and Eriksson, M. Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging. Eur. J. Hum. Genet. 17 (2009) 928-937.
• 92. Goldman, R.D., Shumaker, D.K., Erdos, M.R., Eriksson, M., Goldman, A.E., Gordon, L.B., Gruenbaum, Y., Khuon, S., Mendez, M., Varga, R. and Collins, F.S. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA. 101 (2004) 8963-8968.
• 93. Mallampalli, M.P., Huyer, G., Bendale, P., Gelb, M.H. and Michaelis, S. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA 102 (2005) 14416-14421.
• 94. Toth, J.I., Yang, S.H., Qiao, X., Beigneux, A.P., Gelb, M.H., Moulson, C.L., Miner, J.H., Young, S.G. and Fong, L.G. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc. Natl. Acad. Sci. USA 102 (2005) 12873-12878.
• 95. Capell, B.C., Olive, M., Erdos, M.R., Cao, K., Faddah, D.A., Tavarez, U.L., Conneely, K.N., Qu, X., San, H., Ganesh, S.K., Chen, X., Avallone, H., Kolodgie, F.D., Virmani, R., Nabel, E.G. and Collins, F.S. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc. Natl. Acad. Sci. USA 105 (2008) 15902-15907.
• 96. Yang, S.H., Qiao, X., Fong, L.G. and Youn, S.G. Treatment with a farnesyltransferase inhibitor improves survival in mice with a HutchinsonGilford progeria syndrome mutation. Biochim. Biophys. Acta 1781 (2008) 36-39.
• 97. Yang, S.H., Andres, D.A., Spielmann, H.P., Young, S.G. and Fong, L.G. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated. J. Clin. Invest. 118 (2008) 3291-3300.
• 98. Varela, I., Pereira, S., Ugalde, A.P., Navarro, C.L., Suárez, M.F., Cau, P., Cadiñanos, J., Osorio, F.G., Cobo, J., de Carlos, F., Lèvy, N., Freije, J.M.P. and López-Otín, C. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat. Med. 14 (2008) 767-772.
• 99. Kieran, M.W., Gordon, L. and Kleinman, M. New approaches to progeria. Pediatrics 120 (2007) 834-841.
• 100. Davies, B.S., Barnes, R.H., Tu, Y., Ren, S., Andres, D.A., Spielmann, H.P., Lammerding, J., Wang, Y., Young, S.G. and Fong, L.G. An accumulation of non-farnesylated pre-lamin A causes cardiomyopathy but not progeria. Hum. Mol. Genet. 19 (2010) 2682-2694.
• 101. Caron, M., Auclair, M., Donadille, B., Béréziat, V., Guerci, B., Laville, M., Narbonne, H., Bodemer, C., Lascols, O., Capeau, J. and Vigouroux, C. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with pre-lamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ. 14 (2007) 1759-1767.
• 102. Coffinier, C., Hudon, S.E., Farber, E.A., Chang, S.Y., Hrycyna, C.A., Young, S.G. and Fong, L.G. HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of pre-lamin A in cells. Proc. Natl. Acad. Sci .USA 104 (2007) 13432-13437.
• 103. Huang, S., Chen, L., Libina, N., Janes, J., Martin, G.M., Campisi, J. and Oshima, J. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference. Hum. Genet. (2005) 1-7.
• 104. Fong, L.G., Ng, J.K., Lammerding, J., Vickers, T.A., Meta, M., Cote, N., Gavino, B., Qiao, X., Chang, S.Y., Young, S.R., Yang, S.H., Stewart, C.L., Lee, R.T., Bennett, C.F., Bergo, M.O. and Young, S.G. Pre-lamin A and lamin A appear to be dispensable in the nuclear lamina. J. Clin. Invest. 116 (2006) 743-752.
• 105. Fong, L.G., Vickers, T.A., Farber, E.A., Choi, C., Yun, U.J., Hu, Y., Yang, S.H., Coffinier, C., Lee, R., Yin, L., Davies, B.S., Andres, D.A., Spielmann, H.P., Bennett, C.F. and Young, S. Activating the synthesis of progerin, the mutant pre-lamin A in Hutchinson–Gilford progeria syndrome, with antisense oligonucleotides. Hum. Mol. Genet. 18 (2009) 2462-2471.
• 106. Marji, J., O'Donoghue, S.I., McClintock, D., Satagopam, V.P., Schneider, R., Ratner, D., Worman, H., Gordon, L.B. and Djabali, K. Defective lamin A-Rb signaling in Hutchinson-Gilford Progeria Syndrome and reversal by farnesyltransferase inhibition. PLoS One 5 (2010) e11132.
• 107. Scaffidi, P. and Misteli, T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat. Cell Biol. 10 (2008) 452-459.
• 108. Scaffidi, P. and Misteli, T. Lamin A-dependent nuclear defects in human aging. Science 312 (2006) 1059-1063.
• 109. Espada, J., Varela, I., Flores, I., Ugalde, A.P., Cadinanos, J., Pendas, A.M., Stewar, C.L., Tryggvason, K., Blasco, M.A., Freije, J.M. and Lopez-Otin, C. Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J. Cell Biol. 181 (2008) 27-35.
• 110. Hegele, R.A., Joy, T.R., Al-Attar, S.A. and Rutt, B.K. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J. Lipid Res. 48 (2007) 1433-1444.
• 111. Tilgner, K., Wojciechowicz, K., Jahoda, C., Hutchison, C. and Markiewicz, E. Dynamic complexes of A-type lamins and emerin influence adipogenic capacity of the cell via nucleocytoplasmic distribution of {beta}-catenin. J. Cell Sci. 122 (2009) 401-413.
• 112. Christodoulides, C., Lagathu, C., Sethi, J.K. and Vidal-Puig, A. Adipogenesis and WNT signalling. Trends Endocrinol. Metab. 20 (2009) 16-24.
• 113. Guillet-Deniau, I., Pichard, A.-L., Kone, A., Esnous, C., Nieruchalski, M., Girard, J. and Prip-Buus, C. Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein1c-dependent pathway. J. Cell Sci. 117 (2004) 1937-1944.
• 114. Lloyd, D.J., Trembath, R.C. and Shackleton, S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum. Mol. Genet. 11 (2002) 769-777.
• 115.Javor, E.D., Cochran, E.K., Musso, C., Young, J.R., Depaoli, A.M. and Gorden, P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 54 (2005) 1994-2002.
• 116. Park, J.Y., Javor, E.D., Cochran, E.K., DePaoli, A.M. and Gorden, P. Longterm efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism 56 (2007) 508-516.
• 117. Maraldi, N.M., Capanni, C., Lattanzi, G., Camozzi, D., Facchini, A. and Manzoli, F.A. SREBP1 interaction with pre-lamin A forms: a pathogenic mechanism for lipodystrophic laminopathies. Adv. Enzyme Regul. 48 (2008) 209-223.
• 118. Broers, J.L., Ramaekers, F.C., Bonne, G., Yaou, R.B. and Hutchison, C.J. Nuclear lamins: laminopathies and their role in premature ageing. Physiol. Rev. 86 (2006) 967-1008.
• 119. Méjat, A.V., Decostre, J., Li, L., Renou, A., Kesari, D., Hantaï, C.L., Stewart, X., Xiao, E., Hoffman, G., Bonne, G. and Misteli, T. Lamin A/C – mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy. J. Cell Biol. 184 (2009) 31-44.
• 120. Bridger, J.M., Foeger, N., Kill, I.R. and Herrmann, H. The nuclear lamina. Both a structural framework and a platform for genome organization. FEBS J. 274 (2007) 1354-1361.
• 121. Wilson, K.L. and Foisner, R. Lamin-binding Proteins. Cold Spring Harb Perspect. Biol. 2 (2010) a000554.
• 122. Rzepecki, R. and Fisher, P.A. In vivo phosphorylation of Drosophila melanogaster nuclear lamins during both interphase and mitosis. Cell. Mol. Biol. Lett. 7 (2002) 859-876.
• 123. Zhang, Y.Q. and Sarge, K.D. Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies. J. Cell Biol. 182 (2008) 35-39.
• 124. Cenni, V., Bertacchini, J., Beretti, F., Lattanzi, G., Bavelloni, A., Riccio, M., Ruzzene, M., Marin, O., Arrigoni, G., Parnaik, V., Wehnert, M., Maraldi, N.M., de Pol, A., Cocco, L. and Marmiroli, S. Lamin A Ser404 is a nuclear target of Akt phosphorylation in C2C12 cells. J. Proteome Res. 7 (2008) 4727-4735.
• 125. Tifft, K.E., Bradbury, K.A. and Wilson, K.L. Tyrosine phosphorylation of nuclear-membrane protein emerin by Src, Abl and other kinases. J. Cell Sci. 122 (2009) 3780-3790.
• 126. Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., Stewart, C.L. and Burke, B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147 (1999) 913-920.
• 127. Leung, G.K., Schmidt, W.K., Bergo, M.O., Gavino, B., Wong, D.H., Tam, A., Ashby, M.N., Michaelis, S. and Young, S.G. Biochemical studies of Zmpste24-deficient mice. J. Biol. Chem. 276 (2001) 29051-29058.
• 128. Ozawa, R., Hayashi, Y.K., Ogawa, M., Kurokawa, R., Matsumoto, H., Noguchi, S., Nonaka, I. and Nishino, I. Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles. Am. J. Pathol. 186 (2006) 907-917.
• 129. Arimura, T., Helbling-Leclerc, A., Massart, C., Varnous, S., Niel, F., Lacene, E., Fromes, Y., Toussaint, M., Mura, A.M., Keller, D.I., Amthor, H., Isnard, R., Malissen, M., Schwartz, K. and Bonne, G. Mouse model carrying H222P-LMNA mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum. Mol. Genet. 14 (2005) 155-169.
• 130. Mounkes, L.C., Kozlov, S.V., Rottman, J.N. and Stewart, C.L. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum. Mol. Genet. 14 (2006) 2167-2180.
• 131. Wang, Y., Herron, A.J. and Worman, H.J. Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy. Hum. Mol. Genet. 15 (2006) 2479-2489.
• 132. Nikolova, V., Leimena, C., McMahon, A.C., Tan, J.C., Chandar, S., Jogia, D., Kesteven, S.H., Michalicek, J., Otway, R., Verheyen, F., Rainer, S., Stewart, C.L., Martin, D., Feneley, M.P. and Fatkin, D. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/Cdeficient mice. J. Clin. Invest. 113 (2004) 357-369.
• 133. Alsheimer, M., Liebe, B., Sewell, L., Stewart, C.L., Scherthan, H. and Benavente, R. Disruption of spermatogenesis in mice lacking A-type lamins. J. Cell Sci. 117 (2004) 1173-1178.
• 134. Hale, J.S., Frock, R.L., Mamman, S.A., Fink, P.J. and Kennedy, B.K. Cellextrinsic defective lymphocyte development in Lmna-/- mice. PLoS One 5 (2010) e10127.
• 135. Bergo, M.O. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a pre-lamin A processing defect. Proc. Natl. Acad. Sci. USA 99 (2002) 13049-13054.
• 136. Anjos-Afonso, F., Siapati, E.K. and Bonnet, D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell Sci. 117 (2004) 5655-5664.
• 137. Cousins, J.C., Woodward, K.J., Gross, J.G., Partridge, T.A. and Morgan, J.E. Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal. J. Cell Sci. 117 (2004) 3259-3269.
• 138. D`Ippolito, G., Diabira, S., Howard, G.A., Menei, P., Roos, B.A. and Schiller, P.C. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci. 117 (2004) 2971-2981.
• 139. Mazhari, R. and Hare, J.M. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat. Clin. Pract. Cardiovasc. Med. 4 (2007) S21-26.
• 140. Dwyer, R.M., Khan, S., Barry, F.P., O'Brien, T. and Kerin, M.J. Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Res. Ther. 1 (2010) 25.
• 141. Pistoia, V. and Raffaghello, L. Potential of mesenchymal stem cells for the therapy of autoimmune diseases. Expert Rev. Clin. Immunol. 6 (2010) 211-218.
• 142. Griffin, M., Greiser, U., Barry, F., O'Brien, T. and Ritter, T. Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease. Discov. Med. 9 (2010) 219-223.
• 143. Epting, C.L., Lopez, J.E., Shen, X., Liu, L., Bristow, J. and Bernstein, H.S. Stem cell antigen-1 is necessary for cell-cycle withdrawal and myoblast differentiation in C2C12 cells. J. Cell Sci. 117 (2004) 6185-6195.
• 144. Rivier, F., Alkan, O., Flint, A.F., Muskiewicz, K., Allen, P.D., Leboulch, P. and Gussoni, E. Role of bone marrow cell trafficking in replenishing skeletal muscle SP and MP cell populations. J. Cell Sci. 117 (2004) 1979-1988.
• 145. Banasik, M.B. and McCray, P.B.J. Integrase-defective lentiviral vectors: progress and applications. Gene Ther. 17 (2010) 150-157.
• 146. Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C.C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., Mahlaoui, N., Kiermer, V., Mittelstaedt, D., Bellesme, C., Lahlou, N., Lefrère, F., Blanche, S., Audit, M., Payen, E., Leboulch, P., l'Homme, B., Bougnères, P., Von Kalle, C., Fischer, A., Cavazzana-Calvo, M. and Aubourg, P. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326 (2009) 818-823.

Uwagi

PL

Rekord w opracowaniu.